Basic Information
OliPass has consistently been committed to the revolution of life sciences and the improvement of quality of life. Our research focuses on utilizing our PNA-based new technology to develop the next generation of therapies. OliPass is now a leading biotechnology company, owning the OliPass PNA platform technology, and continuously expanding its operations worldwide.
OliPass Corporation
GyeonggiProvince,SouthKorea
51~100 people
January 01, 2006
rnd@olipass.com
